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NEWS
HHS Takes Steps to Provide More Information About Clinical
Trials to the Public
On September 16, 2016, in an effort to make information about clinical trials widely
available to the public, the U.S. Department of Health and Human Services
(HHS) issued a final rule specifying requirements for registering and
reporting summary results information to Clinical Trials.gov. The new rule
expands the legal requirements for submitting registration and results information for
certain clinical trials involving U.S. Food and Drug Administration (FDA)-regulated
drug, biological and device products to ClinicalTrials.gov. At the same time, the National Institutes of Health
issued a complementary policy for registering and submitting summary results information to
ClinicalTrials.gov for all NIH-funded clinical trials, including those not subject to the final rule. These actions
are important steps to honor our commitments to clinical trial participants to share the knowledge gained
from their participation in order to achieve the greatest benefit to human health.
 
Since many of you are likely to be affected by these changes, we encourage you to read the NIH news
release along with related materials to learn more about these important developments and to contact your
Office of Research for any questions pertaining to this announcement.
DID YOU KNOW?
Pathway to Independence (PI) Working Group
 
The UMass Center for Clinical and Translational Science and the UMMS Office
of Research "R-Club" was established in October 2014. Drs. Beth McCormick
and Robert Goldberg are pleased to announce the third annual offering of
the Pathway to Independence (PI) Club at UMMS, an auxiliary of the "R-Club".
The Pathway to Independence (PI) Club at UMMS is a working group that is available for all current
and past K awardees and junior faculty who are contemplating the submission of an R-type grant (e.g.,
R01, R03, R21) to the NIH during the coming academic year as well as for those who might be considering
foundation or other types of awards. This working group is particularly geared to young investigators who will
be submitting grant proposals as part of their career pathway and are committed to a research career. This
working group is intended to enhance, and not replace, mentoring by peers and senior faculty.
Don't miss out on this excellent learning opportunity!  Learn More 
Research Career Award & Writing Group "K-Club"
Join today!
The UMass Center for Clinical and Translational Science Research Career
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Award & Writing Group "K-Club", established in 2007, is co-lead by Drs.
Douglas Ziedonis and Sherry Pagoto. Most faculty who participate and apply for
a research career award have been very successful in getting funded (>80%
success). The group meets monthly to provide information and feedback on
academic career development and on preparing a Research Career Award
application.
Faculty will receive:
Feedback on CV development
Help on preparing NIH biosketches
Support on creating yearly career development plans
Individualized help on developing career goals and program of research
Support with writing the career development grant application
Guidance on selecting and working with primary and secondary mentors (if needed)
Don't miss out on this great educational opportunity!  Learn More
EVENTS
 October 2016 Events 
Human Research Protection Program (HRPP)
Upcoming Educational Opportunities
Clinical Research Professionals Group (CRPG) Meetings:
Monday, October 17, 2016
2:00 pm - 3:00 pm
Hiatt Auditorium S1-608, UMMS, Worcester
Thursday, November 17, 2016
2:00 pm - 3:00 pm
Hiatt Auditorium S1-608, UMMS, Worcester
Learn More
~New~ HIPAA and Research Series
Mark your calendars! Join us Wednesdays in November for a series on HIPAA and research with joint
presentations from the Privacy Officers, IRB, an IT.
Sign-up for one session or all sessions.
Wednesdays, Amphitheater I, S2-102, UMMS, Worcester
November 2, 2016
4:00 - 5:00 pm
"Basics of HIPAA and Research"
November 9, 2016
8:00 - 9:00 am
"Research, Privacy and the EHR"
November 16, 2016
8:00 - 9:00 am
November 30, 2016
12:00 - 1:00 pm
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"HIPAA Compliance and the Clinical Data" "HIPAA and Data Storage, Handling and
Destruction"
 
Watch the New Release in NRMN's Health
Research Talks Video Series
"What is Community-Based Participatory Research
(CBPR) and Why Do It?" featuring Monica L. Baskin,
PhD
In this fourth installment, Dr. Monica Baskin of the UAB
Division of Preventive Medicine introduces Community-Based Participatory Research (CBPR), its guiding
priciples, CBPR tools in application, and the foremost challenges and opportunities for those engaging in it.
Watch now!
I-Corps Program at the UMCCTS
Register for the second informational session!
Are you interested in the business of science?  Want help translating
your research into better health?
The new I-Corps Program at the UMCCTS, a joint MassTERi/UMass Center for Clinical and
Translational Science initiative, is designed to support the translation of biomedical research by providing
early-stage education and strategic guidance to faculty, staff and students during the ideation phase of
technology development.
This four-week course will be held in the Spring 2017.  Designed specifically for the biomedical
researcher at UMass, it guides interdisciplinary teams through a hands-on process of understanding the
market for their technology utilizing a proven customer discovery methodology.
Please join us for a no-obligation, information session on:
Monday, October 17, 2016
12:00 - 1:00 pm
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John Van Drie, PhD
Owner and President, Van Drie Research, LLC
Pharma experience includes, BioCAD, Pharmacia, Pfizer, Vertex, Novartis 4




Why Do Innovative Drugs "Die" Along the Way?
 
Thursday, October 20, 2016
Multi-Purpose Room EAST, 1st floor
Albert Sherman Center




 4:00-5:00 pm - Lecture and Case Study
5:00-5:30 pm - Networking (refreshments served)
 
Lecture and Case Study:  Some of the principles of innovation will be discussed including the
opposable mind, the role of midnight projects and failure as a metric. The reasons why innovative drugs
always die before they become blockbusters will be discussed. Dr. Van Drie will discuss examples of
innovative drugs that died along the way to becoming a billion dollar blockbuster.
 
This event will be a great opportunity for networking and collaboration too!
 
Upcoming MassTERi Education Seminar:
11/17/16
Structure Activity Relationship (SAR): Moving the Goal Posts
The Diabetes Innovation Challenge
Finals
Please join us for The Diabetes Innovation Challenge final project
presentations.
October 20, 2016
3:30 - 8:30 pm
Royal Sonesta Boston, Cambridge, MA
RSVP now to see the final 8 presentations!
The Diabetes Innovation Challenge seeks to find transformational advancements in diabetes.
The Massachusetts Medical Device Development Center (M2D2) at UMass, in partnership with T1D
Exchange, a nonprofit focused on accelerating innovations that improve outcomes in type 1 diabetes,
present the first Diabetes Innovation Challenge. This exciting multi-staged event is an opportunity to
identify, support and incubate transformational innovations in types 1 and 2 diabetes.
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Rolf Wagner, PhD
Senior Medicinal Chemistry Group Leader, Senior Principal Research Scientist,
AbbVie Chemistry Technologies and Outsourcing
Pharma experience includes Hoffman-LaRoche
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Structure Activity Relationship (SAR):
Moving the Goal Posts
 
Thursday, November 17, 2016
AS9-2072, 9th floor conference room
Albert Sherman Center




4:00-5:00 pm - Lecture and Case Study
5:00-5:30 pm - Networking (refreshments served)
 
Lecture and Case Study:  From Hits to Leads and Lead Optimization, the team has to choose which
compounds to move forward. To do this, a relationship between a structure (i.e., a chemical modification on
a compound) and an activity (potency, solubility, activity in vitro and in vivo, etc., must be understood). The
SAR tables are a chemist's chart that hopefully leads him or her to the Promised Land and a molecule that
will be successful clinically and commercially. Knowing when to change the criteria (the goal posts) is part
of the art of making drugs. Dr. Wagner will share an example of a successful project and the SAR that
drove the project.
 
This event will be a great opportunity for networking and collaboration too!
FUNDING and TRAINING OPPORTUNITIES
IND-Enabling Funding Award
Call for Applications
The UMass Center for Clinical and Translational Science, UMMS Innovation and
Business Development, and MassBiologics of UMMS are pleased to announce
a new funding opportunity to support IND/IDE-Enabling Studies. The purpose
of this program is to assist faculty with the commercial development of UMass discoveries; specifically, to
facilitate additional research and development work directed at enabling first in human studies.
Deadline for applications: October 24, 2016
Learn More
UMass Center for Clinical and Translational Science
Community Research Innovative Scholars Program 
Call for Proposals
The Community Research Innovative Scholars Program (CRISP),
from the Community Engagement and Research component of the UMass Center for Clinical and
Translational Science, is pleased to offer a call for proposals to support the development of independent
UMass researchers who conduct community engaged research. Community engaged research
involves collaborative research with community partners along the translational research
continuum.
Click here for CRISP webinar from 9/12/16.
Deadline for applications: November 1, 2016
Read More
UMass Life Sciences Moment Fund
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Call for Letters of Intent
The UMass Center for Clinical and Translational Science is pleased to
announce a funding call for the UMass Life Sciences Moment Fund
(LSMF) 2016. The UMass LSMF supports projects that are inter-campus in orientation and directed
towards life sciences projects related to clinical and translational research.
Deadline for letters of intent: November 21, 2016
Read More
UMCCTS Pilot Project Program (PPP)
Call for Letters of Intent
The UMass Center for Clinical and Translational Science (UMCCTS) is
announcing the next funding round for the Pilot Project Program (PPP) 2016.
The intent of the funding is to speed up the rate of progress to move a research
project, clinical finding or other discovery into a broader network of activities, while maximizing the breadth
of transdisciplinary skills applied to the research question. We are particularly interested in proposals
which feature a clinical scientist working with a basic scientist, proposals with an emphasis on community-
based research, and proposals that support the career development of new investigators.
Deadline for letters of intent: November 21, 2016
Read More
UMMS Office of Global Health
 Pilot Project Program (OGH-PPP)
Call for Letters of Intent
The UMMS Office of Global Health announces the 2017 OGH-Pilot
Project Program request for proposals. The key goal of OGH-PPP funding is to catalyze the
development of translational research projects that provide a firm scientific basis for clinical practice and
public health policy in global settings. The intent of the OGH-PPP is to promote and prioritize for funding
projects that are innovative, interdisciplinary, evidence-based, capitalize on University of Massachusetts
Medical School (UMMS) programmatic strengths, and that have the best potential for future growth and
external funding.
Deadline for letters of intent: November 21, 2016
Read More
Small Conference Grants are Available!
The UMass Center for Clinical and Translational Science offers Small Conference
Grants (SCG) designed to leverage the convening capacity of the UMCCTS to
create new, multidisciplinary teams to address a pressing health need. The
conference can be a symposium, educational program, seminar, workshop or any
other organized and formal meeting. The goal of the SCG is to facilitate
networking opportunities between faculty that focus on clinical and
translational research.
If you have an idea for an event that a SCG could help fund, visit the UMCCTS website for more information
and RFA or contact Nate Hafer, PhD, Director of Operations, UMCCTS.
University of Massachusetts Medical School
Transdisciplinary Training in 
Cardiovascular Research (T32)
UMass has a cardiovascular T32 training grant entitled "Transdisciplinary
Training in Cardiovascular Research" under the direction and senior
10
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leadership of Drs. Catarina Kiefe and John Keaney.  The program represents a
wonderful opportunity for the institution to promote the entire spectrum (T0-T2+) of cardiovascular research
on our campus.  We are writing to request applications from trainees who wish to become part of this
exciting program at the postdoctoral level. New trainees will join 4 other current trainees in the program.
Eligibility:  Please see http://grants.nih.gov/grants/guide/pa-files/PA-14-015.html
Duration of support: Funding for two years of support provided.  Trainees may apply for an additional
year.
 
Amount of support: Based upon the NIH stipend schedule as outlined in the link below.  Faculty
sponsors may, at their discretion and with department and institutional approval supplement the NIH
stipend, but only from a non-federal, non-sponsored funding source.
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-048.html
Proposals are accepted on a rolling basis.
Learn More
HHMI Launches New Program for Early-Career Scientists
Hanna H. Gray Fellows Program Seeks to Enhance Diversity in
Life Sciences
The Howard Hughes Medical Institute (HHMI) announces a new program to recruit and retain early-career
scientists who are from gender, racial, ethnic, and other groups underrepresented in the life sciences,
including those from disadvantaged backgrounds.
Deadline for applications: February 15, 2017
Learn More
Next-Gen Supply Chain QuickFire Challenge
We're Looking for the Best Biological Technology or Solution
to Award 75,000 USD
At Janssen Supply Chain our goal is to deliver transformational medical
solutions to people around the world. Johnson & Johnson Innovation and Janssen
Supply Chain are looking to award a prize or a series of prizes to the person or
team(s) who submits the best solution to key manufacturing and supply chain challenges that address the
issues of higher costs and reliability in supply chains.
Deadline to apply: November 2, 2016
Learn More
The Doris Duke Charitable Foundation
2017 Clinical Scientist Development Award Competition
Pre-proposals are being sought from junior physician-scientist faculty
conducting clinical research in any disease area. Competitive applicants are
expected to have research experience and publication records consistent with
the rank of assistant professor.
The Clinical Scientist Development Award does not require institutional nomination. This competition
employs a two-stage process. Pre-proposals will be reviewed and up to 50 applicants will be invited to
submit a full proposal.
Pre-proposals Due: November 29, 2016
Learn More 11
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Antimicrobial Resistance Diagnostic Challenge
Can you help create a diagnostic tool for health care providers to
better identify resistant bacterial infections?
The main purpose of the Antimicrobial Resistance Diagnostic Challenge is to
incentivize the development of one or more rapid, point-of-care in vitro diagnostic tests that would be of
significant clinical and public health utility to combat the development and spread of antibiotic resistant
bacteria or diagnostic tests that distinguish between bacterial and viral infections.
$20 million in prize awards
Letters of Intent due December 23, 2016
Learn More
Now Open: 2017 NIH Loan Repayment Programs
The National Institutes of Health (NIH) Loan Repayment
Programs (LRPs) are a set of programs established by Congress and
designed to recruit and retain highly qualified health professionals into
biomedical or biobehavioral research careers. The escalating costs of
advanced education and training in medicine and clinical specialties are forcing some scientists to
abandon their research careers for higher-paying private industry or private practice careers.
LRP is now open and will close on November 15, 2016
Read More
NIH Peer Review Online Briefings for Fellowship and R01 Grant Applicants and
Basic Research Grant Applicants and Reviewers (NOT-OD-16-152)
 
The purpose of this Notice is to inform NIH grant applicants, their mentors, and reviewers about three online
video briefings the NIH Center for Scientific Review (CSR) will host in November and December 2016.
CSR is the portal for NIH grant applications and their review for scientific and technical merit.
 
Each Briefing Will Have a Different Focus
 
Fellowship and R01 grant applicants:  The first two briefings will provide these applicants key information
that could help them better navigate the NIH peer review process.
 
Basic research grant applicants and reviewers:  The third briefing will reaffirm NIH's commitment to basic
research and help applicants and reviewers better do their part in proposing and reviewing basic research.
Briefing Title Date
8 Ways to Successfully Navigate NIH Peer Review and Get a Fellowship
Grant November 2, 2016
8 Ways to Successfully Navigate NIH Peer Review and Get an R01 Grant December 1, 2016
NIH Peer Review Briefing for Basic Research Applicants and Reviewers December 2, 2016
 
All of the briefings will run from 2:00 to about 3:00 p.m. Eastern Time, including a 30 minute Q&A period.
Read More
Harvard Catalyst Course: T3/T4 Research 12
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Harvard Catalyst is accepting applications for the next
iteration of T3/T4 Research.
T3/T4 Research: Translating Effective Interventions into Practice
November 3-4, 2016
Sheraton Commander Hotel, Cambridge, MA
Tuition-free for CTSA-affiliated institutions like UMass!
This two-day introductory course offers an overview of T3/T4 research that focuses on the translation of
findings from research in controlled environments to general clinical practice and population health. The
goal of the T3/T4 research is to address gaps in knowledge that persist after the efficacy and safety of
interventions have been defined in optimal settings. It includes studies designed to encourage the use of
these interventions in routine care settings, both locally and globally, and to modify risk factors for disease.
For additional information and application details, email Harvard Catalyst today:
t3t4_courses@catalyst.harvard.edu
Please remember to cite the CTSA Grant # UL1-TR001453 in all supported journal
publications.
The UMass Center for Clinical and Translational Science (UMCCTS) was founded in 2006 to enhance clinical and
translational research across the five University of Massachusetts campuses and our clinical partner, UMass Memorial
Health Care. With the receipt of an NIH Clinical and Translational Science Award (CTSA) in 2010, and its successful
renewal in 2015, the UMCCTS joined a network of 62 NIH-funded centers collaborating to transform the conduct of clinical
and translational research across the U.S. Other key partners include our patients and communities, foundations,
biotechnology and pharmaceutical companies, and members of the venture capital and philanthropic communities.
We encourage you to browse through our website to learn more about how the UMCCTS catalyzes clinical and
translational research through education and training, pilot funding programs, cores, services and collaboration.
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